Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

North Carolina Gov. Josh Stein announced that Genentech, a biotechnology company, will build a new manufacturing plant in ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

Genentech, one of the world's premiere biotechnology companies headquartered in South San Francisco, California, announced it ...

The project could eventually add more than 400 manufacturing jobs and over 1,500 construction jobs during site development.

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

North Carolina's life sciences sector continues to attract major investments with the potential for thousands of jobs.